Design, synthesis and antileishmanial in vitro activity of new series of chalcones-like compounds: A molecular hybridization approach

被引:43
作者
Barbosa, Ticiano P. [1 ]
Sousa, Suervy C. O. [1 ]
Amorim, Francianne M. [2 ]
Rodrigues, Yara K. S. [2 ]
de Assis, Priscilla A. C. [1 ]
Caldas, John P. A. [3 ]
Oliveira, Marcia R. [2 ,3 ]
Vasconcellos, Mario L. A. A. [1 ]
机构
[1] Univ Fed Paraiba, Dept Quim, Lab Sintese Organ Med Paraiba LASOM PB, BR-58059900 Joao Pessoa, Paraiba, Brazil
[2] Univ Fed Paraiba, Dept Biol Mol, BR-58059900 Joao Pessoa, Paraiba, Brazil
[3] Univ Fed Paraiba, Lab Tecnol Farmaceut, BR-58059900 Joao Pessoa, Paraiba, Brazil
关键词
Molecular hybridization; Morita-Baylis-Hillman adducts; Antileishmanial activity; Methyl salicylate; Acryloyl salicylate; BAYLIS-HILLMAN REACTION; ENANTIOSELECTIVE SYNTHESIS; TRYPANOTHIONE REDUCTASE; VISCERAL LEISHMANIASIS; AMPHOTERICIN-B; MECHANISM; SUBSTITUTION; SALICYLATE; INFECTION; ADDUCTS;
D O I
10.1016/j.bmc.2011.05.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chalcone-like series 1a-1g was efficiently synthesized from Morita-Baylis-Hillman reaction (52-74% yields). Compounds 1a-1g were designed by molecular hybridization based on the anti-inflammatory drug methyl salicylate (3) and the antileishmanial moiety of the Morita-Baylis-Hillman adducts 2a-2g. The 1a-1g compounds were much more actives than precursor series 2a-2g, for example, IC50 = 7.65 mu M on Leishmania amazonensis and 10.14 mu M on Leishmania chagasi (compound 1c) when compared to IC50 = 50.08 mu M on L. amazonensis and 82.29 mu M on L. chagasi (compound 2c). The IC50 values of compound 3 (228.49 mu M on L. amazonensis and 261.45 mu M on L. chagasi) and acryloyl salicylate 4 (108.50 mu M on L. amazonensis and 118.83 mu M on L. chagasi) were determined here, by the first time, on Leishmania. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4250 / 4256
页数:7
相关论文
共 54 条
[1]   Reevaluation of the mechanism of the Baylis-Hillman reaction: Implications for asymmetric catalysis [J].
Aggarwal, VK ;
Fulford, SY ;
Lloyd-Jones, GC .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2005, 44 (11) :1706-1708
[2]   Dualistic Nature of the Mechanism of the Morita-Baylis-Hillman Reaction Probed by Electrospray Ionization Mass Spectrometry [J].
Amarante, Giovanni W. ;
Milagre, Humberto M. S. ;
Vaz, Boniek G. ;
Ferreira, Bruno R. Vilacha ;
Eberlin, Marcos N. ;
Coelho, Fernando .
JOURNAL OF ORGANIC CHEMISTRY, 2009, 74 (08) :3031-3037
[3]   Glutathione-like tripeptides as inhibitors of glutathionylspermidine synthetase. Part 2: Substitution of the glycine part [J].
Amssoms, K ;
Oza, SL ;
Augustyns, K ;
Yamani, A ;
Lambeir, AM ;
Bal, G ;
Van der Veken, P ;
Fairlamb, AH ;
Haemers, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (19) :2703-2705
[4]   Characteristics of known drug space. Natural products, their derivatives and synthetic drugs [J].
Bade, Richard ;
Chan, Ho-Fung ;
Reynisson, Johannes .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (12) :5646-5652
[5]   Molecular Basis of Antimony Treatment in Leishmaniasis [J].
Baiocco, Paola ;
Colotti, Gianni ;
Franceschini, Stefano ;
Ilari, Andrea .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) :2603-2612
[6]   Improved synthesis of seven aromatic Baylis-Hillman adducts (BHA): Evaluation against Artemia salina Leach. and Leishmania chagasi [J].
Barbosa, Ticiano P. ;
Junior, Claudio G. L. ;
Silva, Fabio P. L. ;
Lopes, Horacimone M. ;
Figueiredo, Lucas R. F. ;
Sousa, Suervy C. O. ;
Batista, Guilherme N. ;
da Silva, Thiago G. ;
Silva, Tania M. S. ;
de Oliveira, Marcia R. ;
Vasconcellos, Mario L. A. A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (04) :1726-1730
[7]   Recent Contributions from the Baylis-Hillman Reaction to Organic Chemistry [J].
Basavaiah, Deevi ;
Reddy, Bhavanam Sekhara ;
Badsara, Satpal Singh .
CHEMICAL REVIEWS, 2010, 110 (09) :5447-5674
[8]   The Baylis-Hillman Bromides as Versatile Synthons: A Facile One-Pot Synthesis of Indolizine and Benzofused Indolizine Frameworks [J].
Basavaiah, Deevi ;
Devendar, Badugu ;
Lenin, Dandamudi V. ;
Satyanarayana, Tummanapalli .
SYNLETT, 2009, (03) :411-416
[9]   Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years [J].
Berman, JD .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) :684-703
[10]   Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients [J].
Cagnoni, PJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 :81-86